Last reviewed · How we verify
Birth control plus Brevail
At a glance
| Generic name | Birth control plus Brevail |
|---|---|
| Sponsor | University of Kansas Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Birth control plus Brevail CI brief — competitive landscape report
- Birth control plus Brevail updates RSS · CI watch RSS
- University of Kansas Medical Center portfolio CI